Literature DB >> 23850923

Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle.

Teun van der Bom1, Michiel M Winter, Maarten Groenink, Hubert W Vliegen, Petronella G Pieper, Arie P J van Dijk, Gertjan T Sieswerda, Jolien W Roos-Hesselink, Aeilko H Zwinderman, Barbara J M Mulder, Berto J Bouma.   

Abstract

OBJECTIVES: The aim of this study was to identify which patients with a systemic right ventricle are at risk for clinical events.
BACKGROUND: In patients with congenitally or atrially corrected transposition of the great arteries, worsening of the systemic right ventricle is accompanied by clinical events such as clinical heart failure or the occurrence of arrhythmia.
METHODS: At baseline, all subjects underwent electrocardiography, echocardiography, cardiopulmonary exercise testing, and cardiovascular magnetic resonance imaging. Clinical events comprised death, vascular events, tricuspid regurgitation requiring surgery, worsening heart failure, and (supra)ventricular arrhythmia. A Cox proportional hazards analysis was used to assess the most valuable determinants of clinical events.
RESULTS: A total of 88 patients with a mean age of 33 years were included in the study. Sixty-five percent were men, and 28% had congenitally corrected transposition of the great arteries. During a follow-up period of 4.3 years, 31 patients (35%) experienced 46 clinical events for an annual risk of 12%. Right ventricular end-diastolic volume index measured by means of cardiovascular magnetic resonance imaging or multirow detector computed tomography (hazard ratio: 1.20; p < 0.01) and peak exercise systolic blood pressure (hazard ratio: 0.86; p = 0.02) were the strongest determinants of clinical events. Patients with a right ventricular end-diastolic volume index above 150 ml/m(2) and peak exercise systolic blood pressure below 180 mm Hg were most likely to experience clinical events with an annual event rate of 19% versus 0.9% in patients without these risk factors.
CONCLUSIONS: Patients with a right ventricular end-diastolic volume index above 150 ml/m(2) and peak exercise systolic blood pressure below 180 mm Hg had a 20-fold higher annual event rate than patients without these risk factors. Regular cardiovascular magnetic resonance imaging and exercise testing are important in the risk assessment of these patients.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMR; CPET; ECG; HR; MDCT; NYHA; New York Heart Association; RVEDVi; SBP; TGA; cardiopulmonary exercise testing; cardiovascular magnetic resonance imaging; ccTGA; clinical events; congenitally corrected transposition of the great arteries; electrocardiography; hazard ratio; multidetector-row computed tomography; prognosis; right ventricular end-diastolic volume index; systemic right ventricle; systolic blood pressure; transposition of the great arteries

Mesh:

Year:  2013        PMID: 23850923     DOI: 10.1016/j.jacc.2013.06.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Why right is never left: the systemic right ventricle in transposition of the great arteries.

Authors:  Benjamin R Waterhouse; Katarzyna D Bera
Journal:  J Physiol       Date:  2015-12-01       Impact factor: 5.182

2.  Comparison of systemic right ventricular function in transposition of the great arteries after atrial switch and congenitally corrected transposition of the great arteries.

Authors:  Michael Morcos; Philip J Kilner; David J Sahn; Harold I Litt; Emanuela R Valsangiacomo-Buechel; Florence H Sheehan
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-01       Impact factor: 2.357

3.  Attenuated right ventricular energetics evaluated using ¹¹C-acetate PET in patients with pulmonary hypertension.

Authors:  Keiichiro Yoshinaga; Hiroshi Ohira; Ichizo Tsujino; Noriko Oyama-Manabe; Lisa Mielniczuk; Rob S B Beanlands; Chietsugu Katoh; Katsuhiko Kasai; Osamu Manabe; Takahiro Sato; Satoshi Fujii; Yoichi M Ito; Yuuki Tomiyama; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

4.  Inter- and intra-ventricular dyssynchrony in the systemic right ventricle is a surrogate marker of major cardiac events in mildly symptomatic patients.

Authors:  Yumi Shiina; Kei Inai; Tatsunori Takahashi; Kota Taniguchi; Eri Watanabe; Kenji Fukushima; Koichiro Niwa; Michinobu Nagao
Journal:  Heart Vessels       Date:  2018-02-28       Impact factor: 2.037

Review 5.  Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Authors:  Julia Köbe; Kevin Willy; Lars Eckardt; Helmut Baumgartner; Kristina Wasmer
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 6.  The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult.

Authors:  Matthew Lewis; Marlon Rosenbaum
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 7.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 8.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 9.  Managing Heart Failure in Transposition of the Great Arteries.

Authors:  Sangeeta Shah; Tripti Gupta; Raza Ahmad
Journal:  Ochsner J       Date:  2015

10.  Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events.

Authors:  Odilia I Woudstra; Tjitske E Zandstra; Rosanne F Vogel; Arie P J van Dijk; Hubert W Vliegen; Philippine Kiès; Monique R M Jongbloed; Anastasia D Egorova; Pieter A F M Doevendans; Thelma C Konings; Barbara J M Mulder; Michael W T Tanck; Folkert J Meijboom; Berto J Bouma
Journal:  J Am Heart Assoc       Date:  2021-02-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.